TrialMedicina (Kaunas, Lithuania)2020

Itching Caused by TRPV3 (Transient Receptor Potential Vanilloid-3) Activator Application to Skin of Burn Patients.

Hye One Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.